Aspen Aerogels, Inc. (NYSE:ASPN) Shares Purchased by Loomis Sayles & Co. L P

Loomis Sayles & Co. L P raised its position in Aspen Aerogels, Inc. (NYSE:ASPN) by 22.7% in the third quarter, Holdings Channel reports. The institutional investor owned 1,619,320 shares of the construction company’s stock after purchasing an additional 300,076 shares during the period. Loomis Sayles & Co. L P’s holdings in Aspen Aerogels were worth $44,839,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently modified their holdings of ASPN. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Aspen Aerogels by 10.3% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,310 shares of the construction company’s stock valued at $341,000 after buying an additional 1,339 shares in the last quarter. nVerses Capital LLC increased its holdings in Aspen Aerogels by 45.0% in the 3rd quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock worth $161,000 after acquiring an additional 1,800 shares in the last quarter. Price T Rowe Associates Inc. MD raised its position in Aspen Aerogels by 15.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 14,580 shares of the construction company’s stock worth $257,000 after acquiring an additional 1,938 shares during the period. Point72 Hong Kong Ltd purchased a new position in Aspen Aerogels during the second quarter valued at $84,000. Finally, Quent Capital LLC purchased a new stake in shares of Aspen Aerogels during the third quarter worth about $118,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Aspen Aerogels Price Performance

ASPN stock opened at $15.05 on Tuesday. Aspen Aerogels, Inc. has a 52-week low of $10.31 and a 52-week high of $33.15. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The stock has a market cap of $1.23 billion, a price-to-earnings ratio of 1,506.01 and a beta of 2.21. The business has a fifty day moving average of $20.88 and a two-hundred day moving average of $24.23.

Analyst Upgrades and Downgrades

ASPN has been the topic of several research analyst reports. Barclays lowered their price objective on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a report on Tuesday, November 12th. Roth Mkm dropped their price target on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research report on Friday, November 8th. TD Cowen raised their price objective on Aspen Aerogels from $36.00 to $41.00 and gave the company a “buy” rating in a report on Tuesday, August 20th. HC Wainwright reiterated a “buy” rating and issued a $30.00 price objective on shares of Aspen Aerogels in a report on Wednesday, October 16th. Finally, Piper Sandler decreased their target price on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. One investment analyst has rated the stock with a sell rating, nine have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $28.70.

Insider Transactions at Aspen Aerogels

In other Aspen Aerogels news, CEO Donald R. Young sold 63,355 shares of the firm’s stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the transaction, the chief executive officer now owns 483,640 shares of the company’s stock, valued at $14,523,709.20. This trade represents a 11.58 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Company insiders own 4.30% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.